PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
-1.64%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$13.5B
AUM Growth
-$1.11B
(-7.6%)
Cap. Flow
-$762M
Cap. Flow
% of AUM
-5.65%
Top 10 Holdings %
Top 10 Hldgs %
31.48%
Holding
316
New
26
Increased
60
Reduced
135
Closed
54
Top Buys
| 1 |
Adobe
ADBE
|
$70.4M |
| 2 |
Zscaler
ZS
|
$61.7M |
| 3 |
Datadog
DDOG
|
$44.8M |
| 4 |
Pinduoduo
PDD
|
$44.4M |
| 5 |
Tesla
TSLA
|
$43M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$94.1M |
| 2 |
Apple
AAPL
|
$68.9M |
| 3 |
Mercado Libre
MELI
|
$68.1M |
| 4 |
Alibaba
BABA
|
$59.7M |
| 5 |
Sanofi
SNY
|
$53.9M |
Sector Composition
| 1 | Technology | 41.63% |
| 2 | Healthcare | 21.34% |
| 3 | Financials | 17.68% |
| 4 | Communication Services | 9.74% |
| 5 | Consumer Discretionary | 4.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Intuitive Surgical
ISRG
$163B
| $78M | 0.58% |
266,821
-72,373
| -21% | -$21.2M |
|
52
Biogen
BIIB
$20.5B
| $77.1M | 0.57% |
300,000
-25,000
| -8% | -$6.43M |
|
53
Reinsurance Group of America
RGA
$13.1B
| $72.6M | 0.54% |
500,000
-20,000
| -4% | -$2.9M |
|
|
RCM
54
DELISTED
R1 RCM Inc. Common Stock
RCM
| $70.8M | 0.52% |
4,696,412
+22,550
| +0.5% | +$340K |
|
|
55
Adobe
ADBE
$146B
| $70.4M | 0.52% |
+138,152
| New | +$70.4M |
|
56
monday.com
MNDY
$9.4B
| $68.7M | 0.51% |
431,738
+149,587
| +53% | +$23.8M |
|
57
Celldex Therapeutics
CLDX
$1.51B
| $66.8M | 0.49% |
2,426,756
+10,000
| +0.4% | +$275K |
|
58
Aon
AON
$80.5B
| $66.5M | 0.49% |
205,000
-25,000
| -11% | -$8.11M |
|
|
59
Datadog
DDOG
$46B
| $65.9M | 0.49% |
723,014
+491,749
| +213% | +$44.8M |
|
60
Eli Lilly
LLY
$666B
| $64.5M | 0.48% |
120,050
-16,841
| -12% | -$9.05M |
|
61
Qualcomm
QCOM
$172B
| $64.1M | 0.47% |
576,823
-111,471
| -16% | -$12.4M |
|
62
Ryan Specialty Holdings
RYAN
$7.04B
| $62.3M | 0.46% |
1,287,500
-37,500
| -3% | -$1.82M |
|
|
63
Zscaler
ZS
$41.8B
| $61.7M | 0.46% |
+396,435
| New | +$61.7M |
|
64
Indivior
INDV
$3.09B
| $60.5M | 0.45% |
2,621,150
-428,537
| -14% | -$9.89M |
|
65
Elevance Health
ELV
$69.4B
| $59.8M | 0.44% |
137,344
+49,420
| +56% | +$21.5M |
|
66
Salesforce
CRM
$233B
| $59.8M | 0.44% |
294,656
| – | – |
|
67
Johnson & Johnson
JNJ
$431B
| $57.7M | 0.43% |
370,662
-87,000
| -19% | -$13.6M |
|
68
Confluent
CFLT
$6.4B
| $57.5M | 0.43% |
1,943,168
-537,703
| -22% | -$15.9M |
|
69
Rhythm Pharmaceuticals
RYTM
$6.95B
| $57.3M | 0.42% |
2,500,000
+250,000
| +11% | +$5.73M |
|
70
Airbnb
ABNB
$76.8B
| $56.8M | 0.42% |
413,630
-1,379
| -0.3% | -$189K |
|
71
Berkshire Hathaway Class B
BRK.B
$1.09T
| $54.9M | 0.41% |
156,850
-17,582
| -10% | -$6.16M |
|
72
AbbVie
ABBV
$376B
| $54.7M | 0.41% |
366,872
+8,000
| +2% | +$1.19M |
|
73
MoonLake Immunotherapeutics
MLTX
$3.79B
| $53.5M | 0.4% |
939,012
-676,377
| -42% | -$38.6M |
|
74
Axon Enterprise
AXON
$57.3B
| $52.8M | 0.39% |
265,464
+197,746
| +292% | +$39.3M |
|
|
BPMC
75
DELISTED
Blueprint Medicines
BPMC
| $52.2M | 0.39% |
1,040,000
+540,000
| +108% | +$27.1M |
|